SIV Vaccine Success

A cytomegalovirus-based vaccine eliminated simian immunodeficiency virus from rhesus macaques, raising hopes of a similarly effective HIV vaccine.

By | September 13, 2013

SIV virionNIH, SRIRAM SUBRAMANIAMA vaccine has eliminated simian immunodeficiency virus (SIV) in some rhesus macaques, which remained uninfected for as long as three years post-treatment, according to a study published in Nature yesterday (September 12).

Previously, researchers had shown that about half of rhesus macaques given the vaccine were protected from SIV infection. The new study showed that monkeys given the vaccine and then infected with SIV showed no signs of the virus in their systems even though it had originally taken hold.

“The virus got in, it infected some cells, moved about in various parts of the body, but it was subsequently cleared, so that by two or three years later the monkeys looked like normal monkeys,” study coauthor Louis Picker from Oregon Health and Science University told Gizmodo.

The vaccine contains a cytomegalovirus that expresses SIV proteins, stimulating the immune system to recognize and attempt to eliminate the virus. The researchers now hope to determine whether the vaccine can eliminate SIV if administered after an SIV infection has taken hold, BBC News reported. The researchers hope to launch human trials within two years.

“It’s always tough to claim eradication—there could always be a cell which we didn't analyze that has the virus in it,” Picker told BBC. “But for the most part, with very stringent criteria . . . there was no virus left in the body of these monkeys.”

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. Henrietta Lacks’s Family Seeks Compensation
  2. Broad Wins CRISPR Patent Interference Case
    Daily News Broad Wins CRISPR Patent Interference Case

    The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.

  3. Humans Never Stopped Evolving
    Features Humans Never Stopped Evolving

    The emergence of blood abnormalities, an adult ability to digest milk, and changes in our physical appearance point to the continued evolution of the human race.

  4. Abundant Sequence Errors in Public Databases
Business Birmingham